Evidence map›Paper›PMID 11263507›Full record

ArticleJournal of neuro-oncology2000

Cerebral metastases as first symptom of cancer: a clinico-pathologic study.

M T Giordana, S Cordera, A Boghi

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Metastatic Lesions of the Brain and Spine.Advances in experimental medicine and biology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Gliadel for brain metastasis.Surgical neurology international · 2013
    Article
  14. Review
  15. Epidemiology of brain metastases.Current oncology reports · 2012
    Article
  16. Article
  17. The price of diagnosis.The British journal of general practice : the journal of the Royal College of General Practitioners · 2008
    Article
  18. Review
  19. Clinical features of primary brain tumours: a case-control study using electronic primary care records.The British journal of general practice : the journal of the Royal College of General Practitioners · 2007
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

M T GiordanaDepartment of Neuroscience, University of Turin, Italy. giordana@medfarm.unito.it
S Cordera
A Boghi
University of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Symptomatic brain metastases of carcinomas in patients without a previously diagnosed malignancy are frequent in neurosurgical series. Such tumors often lack distinctive morphological characteristics so that the routine histological examination can be unsuccessful in identifying the site of origin. Objectives of the present study were to evaluate the frequency of brain metastases as the only manifestation of an unknown primary cancer by the retrospective analysis of a series of consecutively operated single cerebral metastases; to verify the efficacy of clinical investigations in detecting the site of origin; to investigate whether the primary site can be identified by the immunohistochemical study of the neurosurgical specimens. Antibodies to the following antigens were used: carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 19.9, CA 125, BCA-225, cytokeratin 20, PSA, HMB-45. Out of 181 patients operated for single cerebral metastasis of carcinoma, 99 (54.7%) were in patients without any previously diagnosed systemic neoplasm. In 26.7% the primary remained undiagnosed after clinical investigations, in 9 cases even at autopsy. PSA and HMB45 antibodies specifically identified metastases from prostate carcinomas and skin melanomas, respectively. No other specific immunophenotype was identified; the immunoreactivity of the single cases was more or less suggestive for a primary site. Precocious metastases of lung carcinomas expressed CEA more frequently than late metastases. It has been hypothesized that CEA plays some role as a contact mediating device. CEA expression can have some link with the tendency to metastasize precociously to the brain. No major difference of p53 and k-ras expression has been found in precocious versus late brain metastases.

Indexed as

AdultAgedAntigens, NeoplasmBiomarkers, TumorBrain NeoplasmsCarcinoembryonic AntigenFemaleHumansImmunoenzyme TechniquesIntermediate Filament ProteinsKeratin-20MaleMelanoma-Specific AntigensMiddle AgedNeoplasm ProteinsNeoplasms, Unknown PrimaryAntigens, NeoplasmBiomarkers, TumorCarcinoembryonic AntigenHRAS protein, humanIntermediate Filament ProteinsKeratin-20KRT20 protein, humanMelanoma-Specific AntigensNeoplasm ProteinsProto-Oncogene Proteins p21(ras)Tumor Suppressor Protein p53

Identifiers

PMID11263507
OpenAlexW1826665863

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.